Christina Kay - Integrated Biopharma Executive VP and Director

INBPDelisted Stock  USD 0.23  0.01  4.55%   

Director

Ms. Christina Kay serves as CoChief Executive Officer, Executive Vice President, Director of Integrated BioPharma, Inc. She has served as Vice President and director of the Company since December 1994, and as Executive Vice President since November 2005. Ms. Kay is not a director of any other public company. since 2019.
Age 53
Tenure 5 years
Phone888 319 6962
Webhttps://www.ibiopharma.com

Integrated Biopharma Management Efficiency

The company has return on total asset (ROA) of 0.0336 % which means that it generated a profit of $0.0336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1268 %, meaning that it created $0.1268 on every $100 dollars invested by stockholders. Integrated Biopharma's management efficiency ratios could be used to measure how well Integrated Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 53 K in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. Integrated Biopharma has a current ratio of 3.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Integrated Biopharma until it has trouble settling it off, either with new capital or with free cash flow. So, Integrated Biopharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Integrated Biopharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Integrated to invest in growth at high rates of return. When we think about Integrated Biopharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Wing LeungHighway Holdings Limited
60
Dr MAElectrovaya Common Shares
74
Ping WongHighway Holdings Limited
47
Darren BlaneyAssetMark Financial Holdings
N/A
Shlomo TamirHighway Holdings Limited
66
Sean PownallAssetMark Financial Holdings
N/A
Wilmot KiddSilvercrest Asset Management
76
Dennis EdwardsAssetMark Financial Holdings
N/A
Tiko AharonovHighway Holdings Limited
66
Kyle OLearyElectrovaya Common Shares
N/A
Lorena CardenasSilvercrest Asset Management
N/A
Winthrop ConradSilvercrest Asset Management
68
Kuang YangHighway Holdings Limited
56
Brian GearyHighway Holdings Limited
56
Sudhin ShahaniSurf Air Mobility
41
Sean JDBlue Owl Capital
44
Uri OppenheimerHighway Holdings Limited
77
Jason RoyElectrovaya Common Shares
N/A
Brian DunnSilvercrest Asset Management
61
Richard PechterSilvercrest Asset Management
69
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people. Integrated Biopharma [INBP] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Integrated Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Integrated Biopharma Leadership Team

Elected by the shareholders, the Integrated Biopharma's board of directors comprises two types of representatives: Integrated Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integrated. The board's role is to monitor Integrated Biopharma's management team and ensure that shareholders' interests are well served. Integrated Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integrated Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Riva Sheppard, Executive Vice President Director
Robert Canarick, Independent Director
Carl DeSantis, Director
William Milmoe, Director
Schild OBE, Chief iBioPharma
Dina Masi, CFO, Sr. VP and Secretary
Nickolas Palin, Pres Segment
Robert Erwin, Pres iBioPharma
Gerald Kay, Chairman, CEO and Pres
Joseph LaPlaca, Director
Jamie Levey, Head Relations
Christina Kay, Executive VP and Director
Orn Adalsteinsson, Chief Inc

Integrated Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Integrated Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Integrated Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Integrated Biopharma's short interest history, or implied volatility extrapolated from Integrated Biopharma options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Integrated OTC Stock

If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA